CLASS II Device recall · Reported 8 Jan 2020 · FDA Enforcement Report

Blood Glucose Monitoring System recalled by Roche Diabetes Care

Roche Diabetes Care is recalling Blood Glucose Monitoring System, distributed nationwide in the US. The recall was initiated on 30 Sep 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel Number : 08453071001 Device Identifier: 00365702729100 All serial numbers below XXX11000001 (where XXX is the first 3 digits of the serial number).
Quantity recalled3,996

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0750-2020
FDA event ID
84119
Recalling firm
Roche Diabetes Care, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
30 Sep 2019
FDA classified
30 Dec 2019
Reported
8 Jan 2020
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Other Reasons

Timeline

30 Sep 2019Recall initiated by company
30 Dec 2019Classified by FDA+91 days
8 Jan 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential power issues with the Accu-Chek¿ Guide Blood Glucose Monitoring System.

Product as listed by the FDA

Blood Glucose Monitoring System, Model Number 08453071001 ACCU-CHEK GUIDE RETAIL KIT FCN MG/DL US - Product Usage: The Accu-Chek Guide Blood Glucose Monitoring System is intended to quantitatively measure glucose in fresh capillary whole blood from the fingertip, palm, and upper arm as an aid in monitoring the effectiveness of glucose control. The Accu-Chek Guide blood Glucose Monitoring System is intended for in vitro diagnostic single-patient use by people with diabetes. The Accu-Chek Guide Blood Glucose Monitoring System is intended to be used by a single person and should not be shared.

Where it was distributed

US Nationwide distribution and countries of AR, AT, AU, BE, BR, CA, CH, CL, DE, DK, EC, ES, FI, FR, GB, GR, HK, HR, ID, IN, IT, JP, KR, LB, LT, LU, MM, MY, NL, NO, PH, PK, PT, SE, SG, TH, TW, ZA.

Nationwide ArkansasCaliforniaDelawareIdahoIndiana

Questions about this recall

Is Blood Glucose Monitoring System recalled?

Yes. Roche Diabetes Care recalled Blood Glucose Monitoring System on 30 Sep 2019. The recall is Class II and its status is Terminated. Recall number Z-0750-2020.

Why was it recalled?

Potential power issues with the Accu-Chek¿ Guide Blood Glucose Monitoring System.

Which lots are affected?

Model Number : 08453071001 Device Identifier: 00365702729100 All serial numbers below XXX11000001 (where XXX is the first 3 digits of the serial number).

Where was it sold?

US Nationwide distribution and countries of AR, AT, AU, BE, BR, CA, CH, CL, DE, DK, EC, ES, FI, FR, GB, GR, HK, HR, ID, IN, IT, JP, KR, LB, LT, LU, MM, MY, NL, NO, PH, PK, PT, SE, SG, TH, TW, ZA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diabetes Care

All 29

Other Insulin Pumps & Glucose Monitors recalls

All 459